We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+12.34%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$78.9B
AUM Growth
+$12.5B
(+19%)
Cap. Flow
+$4.74B
Cap. Flow
% of AUM
6.01%
Top 10 Holdings %
Top 10 Hldgs %
15.31%
Holding
3,573
New
822
Increased
973
Reduced
952
Closed
730
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.03B |
| 2 |
Microsoft
MSFT
|
+$736M |
| 3 |
Apple
AAPL
|
+$435M |
| 4 |
Tesla
TSLA
|
+$381M |
| 5 |
Meta Platforms (Facebook)
META
|
+$332M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$470M |
| 2 |
Brown & Brown
BRO
|
+$433M |
| 3 |
Intuit
INTU
|
+$310M |
| 4 |
Amazon
AMZN
|
+$292M |
| 5 |
Dollar Tree
DLTR
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.77% |
| 2 | Financials | 9.44% |
| 3 | Industrials | 7.97% |
| 4 | Consumer Discretionary | 7.81% |
| 5 | Healthcare | 6.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
CALL
Thermo Fisher Scientific
TMO
$220B
| $4.07M | 0.01% |
8,400
-23,700
| -74% | -$11M |
|
1427
CALL
Nextpower Inc
NXT
$15.9B
| $4.07M | 0.01% |
55,000
+44,500
| +424% | +$2.87M |
|
|
SARO
1428
StandardAero Inc
SARO
$8.97B
| $4.06M | 0.01% |
148,887
-2,140,766
| -93% | -$60.1M |
|
1429
PUT
Edwards Lifesciences
EW
$53.4B
| $4.06M | 0.01% |
52,200
+36,100
| +224% | +$2.82M |
|
1430
Huntington Bancshares
HBAN
$35.9B
| $4.05M | 0.01% |
234,772
+118,775
| +102% | +$2.03M |
|
1431
PUT
Floor & Decor
FND
$6.27B
| $4.05M | 0.01% |
+55,000
| New | +$4.51M |
|
1432
CALL
RH
RH
$3.4B
| $4.04M | 0.01% |
19,900
+100
| +0.5% | +$21.7K |
|
1433
MYR Group
MYRG
$5.1B
| $4.04M | 0.01% |
19,434
+14,659
| +307% | +$2.74M |
|
1434
CALL
AstraZeneca
AZN
$244B
| $4.04M | 0.01% |
+26,300
| New | +$3.98M |
|
1435
Summit Therapeutics
SMMT
$11.2B
| $4.03M | 0.01% |
+194,851
| New | +$4.73M |
|
|
PRMB
1436
Primo Brands
PRMB
$8.97B
| $4.02M | 0.01% |
181,943
+68,571
| +60% | +$1.77M |
|
1437
Centrus Energy
LEU
$3.83B
| $4.02M | 0.01% |
12,954
+2,916
| +29% | +$645K |
|
1438
Sunrun
RUN
$2.37B
| $4.02M | 0.01% |
232,277
-830,346
| -78% | -$11.1M |
|
1439
PUT
iShares Bitcoin Trust
IBIT
$47.2B
| $4.01M | 0.01% |
+61,700
| New | +$4.01M |
|
1440
UMB Financial
UMBF
$11.5B
| $4M | 0.01% |
33,812
+23,192
| +218% | +$2.67M |
|
|
IMSRW
1441
Terrestrial Energy Warrant
IMSRW
$31.1M
| $4M | 0.01% |
660,000
+85,000
| +15% | +$237K |
|
|
ACLX
1442
DELISTED
Arcellx
ACLX
| $4M | 0.01% |
48,691
-6,101
| -11% | -$439K |
|
1443
PUT
Opendoor
OPEN
$3.54B
| $3.98M | 0.01% |
+516,667
| New | +$2.1M |
|
|
1444
CALL
Edwards Lifesciences
EW
$53.4B
| $3.97M | 0.01% |
51,100
+35,600
| +230% | +$2.78M |
|
1445
PUT
First Solar
FSLR
$24B
| $3.97M | 0.01% |
18,000
-50,100
| -74% | -$9.62M |
|
|
SRDX
1446
DELISTED
Surmodics
SRDX
| $3.96M | 0.01% |
132,455
-139,227
| -51% | -$4.65M |
|
1447
Annexon
ANNX
$862M
| $3.96M | 0.01% |
+1,297,260
| New | +$3.22M |
|
1448
Avista
AVA
$3.24B
| $3.95M | 0.01% |
104,504
-59,097
| -36% | -$2.2M |
|
|
ARI
1449
Apollo Commercial Real Estate
ARI
$886M
| $3.95M | 0.01% |
389,566
+57,708
| +17% | +$588K |
|
1450
PUT
Boston Scientific
BSX
$74.9B
| $3.92M | 0.01% |
40,200
+1,100
| +3% | +$114K |
|
Similar funds
BC
Balyasny Asset Management's Q3 2025 Portfolio in Review
As of Q3 2025, Balyasny Asset Management held 3,573 positions worth $78.9B, up 19% from $66.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Balyasny Asset Management deployed $4.74B of net new capital in Q3 2025, opening 822 new positions and adding to 973 existing holdings. Its largest new stake was Aon: 846,715 shares worth $302M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Brown & Brown, an estimated $433M trimmed.
- Balyasny Asset Management's largest Q3 2025 buy was Aon: 846,715 shares worth $302M.
- Balyasny Asset Management added most to iShares Core S&P 500 ETF in Q3 2025, an estimated $1.03B increase.
- Balyasny Asset Management's biggest Q3 2025 reduction was Brown & Brown, cutting an estimated $433M.
- Balyasny Asset Management fully exited Arista Networks in Q3 2025, selling an estimated $470M.
- Balyasny Asset Management's ten largest holdings make up 15% of its $78.9B portfolio in Q3 2025.
- Balyasny Asset Management opened 822 new positions and closed 730 in Q3 2025.
- Balyasny Asset Management's portfolio value rose 19% quarter-over-quarter to $78.9B.
Based on Balyasny Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.